Search results for: “oncology”
-
Genetic Technologies acquires EasyDNA for $4.0 million
•
MELBOURNE, AUSTRALIA: Genetic Technologies Limited (GTG) has entered into an agreement to acquire the direct-to-consumer eCommerce business and…
-
ViiV Healthcare and Halozyme enter global collaboration and license agreement for HIV medicine
•
LONDON, UK: Halozyme‘s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable…
-
PDS Biotechnology Corporation commences public offering of shares at Nasdaq
•
LONDON, UK: NetScientific plc announced that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB) commenced an underwritten public…
-
Onxeo SA forms advisory committee of leading independent experts
•
PARIS, FRANCE: Onxeo S.A., a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA…
-
Palla Pharma appoints Giles Moss as new CEO
•
SYDNEY, AUSTRALIA: Palla Pharma Limited announced that Mr Giles Moss has been appointed as the new Chief Executive…
-
NeoGenomics Inc. acquires Inivata Limited
•
LONDON: Schroder UK Public Private Trust’s portfolio company Inivata Limited has been acquired by NeoGenomics Inc., a leading…
-
Sanofi completes acquisition of Kiadis Pharma
•
AMSTERDAM: Sanofi has completed the acquisition of Kiadis, a clinical-stage biopharmaceutical company developing next generation ‘off-the-shelf’ NK cell-therapies,…
-
Artios collaborates with Novartis to create next generation DDR cancer therapies
•
LONDON: Arix Bioscience’s portfolio company Artios Pharma Limited announced a global research collaboration with Novartis to discover and…
-
Oncimmune Holdings signs agreements with Roche and Cedars-Sinai
•
LONDON: Oncimmune Holdings plc has signed two separate agreements with Roche Pharmaceuticals and Cedars-Sinai Medical Center, in each…
-
Oxford Biomedica Plc (LSE:OXB)
•
Oxford Biomedica Plc (LSE:OXB) is a leading, fully integrated, gene and cell therapy group focused on developing life…
-
Tryp Therapeutics appoints Greg McKee as Chief Executive Officer
•
SAN DIEGO: Tryp Therapeutics Inc. has appointed Greg McKee as its Chief Executive Officer, a news release said.…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.